A South Korean biotech’s GLP-1 candidate has reduced liver fat in patients with metabolic dysfunction-associated ...

Rivus Pharmaceuticals’ fat-busting, muscle-sparing drug candidate reduced liver fat in a phase 2 trial while showcasing the ...

South Korea’s clinical-stage biotech D&D Pharmatech saw its share leap as much as 30% as it revealed “remarkably positive” ...

South Korea, February 1960 ... Sioux helicopter for hospitalization at the 44th Mobile Army Surgical Hospital (MASH). Pictured here is a scan of the original 1960 print created by Stars and ...

A lthough MASH is often remembered as a hilarious sitcom, the show’s greatest trick was sneaking one timeless message into every episode of the series. Set in Uijeongbu, South Korea during the ...

“We are pleased to report that we have completed enrollment in our Phase 2 trial investigating DD01 in MASH patients,” said Seulki Lee, Ph.D., President and Chief Executive Officer of D&D ...